newsfilter
← Latest News
PR Newswire·

Kintara Therapeutics Presents Three Posters at the 2022 Society for Neuro-Oncology Annual Meeting

SAN DIEGO, Nov. 18, 2022 /PRNewswire/ -- Kintara Therapeutics, Inc.(NASDAQ:KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies,